GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » U-Neuron Biomedical Inc (ROCO:6973) » Definitions » Price-to-Operating-Cash-Flow

U-Neuron Biomedical (ROCO:6973) Price-to-Operating-Cash-Flow : (As of Jun. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is U-Neuron Biomedical Price-to-Operating-Cash-Flow?

As of today (2024-06-09), U-Neuron Biomedical's share price is NT$46.90. U-Neuron Biomedical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-1.80. Hence, U-Neuron Biomedical's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for U-Neuron Biomedical's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:6973's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.29
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

U-Neuron Biomedical's Cash Flow from Operations per share for the six months ended in Dec. 2023 was NT$-0.62. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-1.80.


U-Neuron Biomedical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for U-Neuron Biomedical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U-Neuron Biomedical Price-to-Operating-Cash-Flow Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - -

U-Neuron Biomedical Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow - - - - -

Competitive Comparison of U-Neuron Biomedical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, U-Neuron Biomedical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


U-Neuron Biomedical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's Price-to-Operating-Cash-Flow falls into.



U-Neuron Biomedical Price-to-Operating-Cash-Flow Calculation

U-Neuron Biomedical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=46.90/-1.8
=

U-Neuron Biomedical's Share Price of today is NT$46.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-1.80.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

U-Neuron Biomedical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


U-Neuron Biomedical (ROCO:6973) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.

U-Neuron Biomedical (ROCO:6973) Headlines

No Headlines